Through MR analysis of these complications, we examined the effects of three common cholesterol-lowering drug targets (HMGCR, PCSK9, and NPC1L1) on three major diabetic microvascular complications: diabetic retinopathy, diabetic nephropathy, and diabetic neuropathy. Here, HMGCR is linked to diabetic neuropathy.